BNTX
BioNTech SE
$98.72
+$2.50(+2.60%)
54
Overall
--
Value
54
Tech
--
Quality
Market Cap
$23.82B
Volume
741.52K
52W Range
$81.20 - $129.27
Target Price
$135.41
Order:
Income Statement
| Metric | Trend | Chart | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Total Revenue | $108.6M | $482.3M | $19.0B | $17.3B | $3.8B | $2.8B | ||
| Total Revenue | $108.6M | $482.3M | $19.0B | $17.3B | $3.8B | $2.8B | ||
| COST OF GOODS SOLD | ||||||||
| Cost of Revenue | $17.4M | $59.3M | $2.9B | $3.0B | $599.8M | $541.3M | ||
| GROSS PROFIT | ||||||||
| Gross Profit | $91.2M | $423.0M | $16.1B | $14.3B | $3.2B | $2.2B | ||
| OPERATING EXPENSES | ||||||||
| Operating Expenses | $277.5M | $755.9M | $-200.1M | $-477.8M | $2.5B | $3.5B | ||
| Research & Development | $226.5M | $645.0M | $949.2M | $1.6B | $1.8B | $2.3B | ||
| Research Expense | $226.5M | $645.0M | $949.2M | $1.6B | $1.8B | $2.3B | ||
| Selling, General & Administrative | $48.3M | $108.5M | $-328.9M | $-544.2M | $557.7M | $599.0M | ||
| Selling & Marketing Expenses | $2.7M | $14.5M | $-50.4M | $-51.7M | $62.7M | $67.9M | ||
| General & Administrative Expenses | $45.5M | $94.0M | $-278.5M | $-492.5M | $495.0M | $531.1M | ||
| Salaries & Wages | $326.0K | $-179.4M | $-90.5M | $-153.7M | -- | -- | ||
| Depreciation & Amortization | $-4.7M | $-6.3M | $-7.3M | $-58.8M | -- | -- | ||
| Depreciation & Amortization | $-4.7M | $-6.3M | $-7.3M | $-58.8M | -- | -- | ||
| Securities Amortization | -- | $2.0M | -- | -- | -- | -- | ||
| Other Operating Expenses | $739.0K | $2.4M | $136.1M | $66.4M | $188.0M | $670.9M | ||
| OPERATING INCOME | ||||||||
| Operating income | $-186.3M | $-332.9M | $14.9B | $12.3B | $690.4M | $-1.3B | ||
| EBITDA | $-327.3M | $-105.1M | $15.0B | $12.4B | $1.4B | $-352.3M | ||
| NON-OPERATING ITEMS | ||||||||
| Interest Expense (Non-Operating) | -- | $2.0M | $-5.4M | $-16.2M | $23.9M | $27.4M | ||
| Intinc | $-174.9M | $1.6M | $1.5M | $48.5M | $519.6M | $664.0M | ||
| Net Non-Operating Interest Income/Expense | $-174.9M | $1.6M | $-25.8M | $29.6M | $495.7M | $636.6M | ||
| Gain on Sale of Securities | -- | -- | $154.1M | $623.7M | -- | -- | ||
| Other Income/Expense | $-1.5M | $-15.2M | $-156.3M | $-623.7M | $-67.8M | -- | ||
| Other Special Charges | $1.5M | $239.0M | $61.0M | $46.5M | $37.4M | -- | ||
| SPECIAL ITEMS | ||||||||
| Restructring And Mn A Income | -- | -- | $305.1M | -- | $29.4M | -- | ||
| Special Income Charges | -- | $-65.0M | $2.2M | $484.6M | $-29.4M | -- | ||
| PRE-TAX INCOME | ||||||||
| EBIT | $-361.2M | $-143.8M | $14.9B | $12.3B | $1.2B | $-650.3M | ||
| Pre-Tax Income | $-361.2M | $-381.1M | $15.0B | $13.0B | $1.2B | $-677.7M | ||
| INCOME TAX | ||||||||
| Tax Provision | $-268.0K | $-161.0M | $4.8B | $3.5B | $255.8M | $-12.4M | ||
| NET INCOME | ||||||||
| Net Income | $-361.1M | $15.2M | $10.3B | $9.4B | $930.3M | $-665.3M | ||
| Net Income (Continuing Operations) | $-361.1M | $-220.1M | $9.7B | $8.6B | $930.3M | $-665.3M | ||
| Net Income (Discontinued Operations) | $-361.1M | $15.2M | $10.3B | $9.4B | $930.3M | $-665.3M | ||
| Net Income (Common Stockholders) | $-361.1M | $15.2M | $10.3B | $9.4B | $930.3M | $-665.3M | ||
| Normalized Income | -- | -- | -- | -- | $871.8M | $-690.1M | ||
| TOTALS | ||||||||
| Total Expenses | $294.9M | $815.2M | $4.6B | $5.5B | $3.1B | $4.1B | ||
| SHARE & EPS DATA | ||||||||
| Average Shares Outstanding | -- | -- | -- | $243.3M | $240.6M | -- | ||
| Average Shares Outstanding (Diluted) | -- | -- | -- | $243.3M | $242.7M | -- | ||
| Shares Outstanding | $226.8B | $241.5B | $246.8M | $241.0M | $240.0M | $240.0M | ||
| Basic EPS | -- | -- | -- | $38.78 | $3.87 | -- | ||
| Basic EPS (Continuing Operations) | -- | -- | -- | $38.78 | $3.87 | -- | ||
| Diluted EPS | -- | -- | -- | $37.77 | $3.83 | -- | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | $37.77 | $3.83 | -- | ||
| OTHER METRICS | ||||||||
| Acquisition Expense | -- | -- | $305.1M | -- | $7.9M | -- | ||
| Insurance And Claims | -- | -- | $-30.4M | $-21.3M | -- | -- | ||
| Minority Interests | $-116.0K | -- | -- | -- | -- | -- | ||
| Other Costof Revenue | -- | -- | -- | -- | $599.8M | $541.3M | ||
| Other Gand A | $45.5M | $94.0M | $-278.5M | $-492.5M | $495.0M | $531.1M | ||
| Other Taxes | $1.7M | -- | -- | -- | -- | -- | ||
| Other Write Down | $326.0K | -- | -- | -- | -- | -- | ||
| Realized Capital Gain | -- | $15.2M | -- | -- | -- | -- | ||
| Selling Expense | $2.7M | $14.5M | $50.4M | $59.5M | -- | -- | ||
| Write Down | -- | $65.0M | $-194.6M | $-484.6M | -- | -- | ||
| Restruct | -- | -- | $305.1M | -- | $29.4M | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BNTX | $98.72 | +2.6% | 741.52K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |